Abstract:NOXA, a BH3-only proapoptotic protein involved in regulating cell death decisions, is highly expressed but short-lived in colorectal cancer (CRC). Neddylated cullin-5 (CUL5)-mediated ubiquitination and degradation of NOXA is crucial to prevent its overaccumulation and maintain an appropriate action time. However, how this process is manipulated by CRC cells commonly exposed to oxidative stress remain unknown. The peroxiredoxin PRDX1, a conceivable antioxidant overexpressed in CRC tissues, has been shown to inhibit apoptosis and TRAF6 ubiquitin-ligase activity. In this study, we found that PRDX1 inhibits CRC cell apoptosis by downregulating NOXA. Mechanistically, PRDX1 promotes NOXA ubiquitination and degradation, which completely depend on CUL5 neddylation. Further studies have demonstrated that PRDX1 oligomers bind with both the Nedd8-conjugating enzyme UBE2F and CUL5 and that this tricomplex is critical for CUL5 neddylation, since silencing PRDX1 or inhibiting PRDX1 oligomerization greatly dampens CUL5 neddylation and NOXA degradation. An increase in reactive oxygen species (ROS) is not only a hallmark of cancer cells but also the leading driving force for PRDX1 oligomerization. As shown in our study, although ROS play a role in upregulating NOXA mRNA transcription, ROS scavenging in CRC cells by N-acetyl-L-cysteine (NAC) can significantly reduce CUL5 neddylation and extend the NOXA protein half-life. Therefore, in CRC, PRDX1 plays a key role in maintaining intracellular homeostasis under conditions of high metabolic activity by reinforcing UBE2F-CUL5-mediated degradation of NOXA, which is also evidenced in the resistance of CRC cells to etoposide treatment. Based on these findings, targeting PRDX1 could be an effective strategy to overcome the resistance of CRC to DNA damage-inducing chemotherapeutics.

Autophagy Regulates Apoptosis by Targeting NOXA for Degradation.

Interplay Between Apoptosis and Autophagy in Colorectal Cancer

XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling.

Cullin-5 Neddylation-Mediated NOXA Degradation is Enhanced by PRDX1 Oligomers in Colorectal Cancer

XIAP Facilitates Breast and Colon Carcinoma Growth Via Promotion of P62 Depletion Through Ubiquitination-Dependent Proteasomal Degradation

Bcl‐2 and Bcl‐xL Play Important Roles in the Crosstalk Between Autophagy and Apoptosis

[The NOXA Promoter Could Function As an Active Enhancer to Regulate the Expression of BCL2 in the Apoptosis Response].

Noxa-Induced Alterations In The Bax/Smac Axis Enhance Sensitivity Of Ovarian Cancer Cells To Cisplatin

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies

Proteasome inhibition induces apoptosis through simultaneous inactivation of MCL-1/BCL-XL by NOXA independent of CHOP and JNK pathways

XBP-1u Suppresses Autophagy by Promoting the Degradation of FoxO1 in Cancer Cells

Noxa/Mcl-1 Balance Regulates Susceptibility of Cells to Camptothecin-Induced Apoptosis

Nitric oxide inhibits autophagy and promotes apoptosis in hepatocellular carcinoma.

XIAP and Ciap1 Amplifications Induce Beclin 1-Dependent Autophagy Through NFκB Activation.

Disruption of WSB2-mediated NOXA Degradation Induces Synthetic Lethality to Anti-apoptotic BCL-2 Family Protein Inhibitors

Novel Role of Nox in Supporting Aerobic Glycolysis in Cancer Cells with Mitochondrial Dysfunction and As A Potential Target for Cancer Therapy

The Critical Molecular Interconnections in Regulating Apoptosis and Autophagy

p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents.

Tumor Cell-Selective Regulation Of Noxa By C-Myc In Response To Proteasome Inhibition

Cross Talk Between Autophagy and Apoptosis Contributes to ZnO Nanoparticle-Induced Human Osteosarcoma Cell Death